ArticleCureus2026
Cerebral Amyloid Angiopathy-Related Inflammation Mimicking Posterior Reversible Encephalopathy Syndrome: A Case Report of Subacute Gerstmann Syndrome in an Elderly Patient.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cerebral amyloid angiopathy-related inflammation (CAA-RI) is a rare immune-mediated complication of cerebral amyloid angiopathy in elderly patients and may closely mimic posterior reversible encephalopathy syndrome (PRES) both clinically and radiologically, making diagnosis challenging. Even though there is an apparently favorable initial outcome after steroid or immunosuppressive treatment, the CAA-RI course is unpredictable and may be associated with relapse or unfavorable neurological outcomes. We report a 76-year-old woman who presented with alexia, acalculia, mild right hemiparesis, and diplopia, consistent with a partially expressed Gerstmann syndrome. Cerebrospinal fluid analysis showed elevated protein without pleocytosis, while the electroencephalography (EEG) demonstrated focal slowing. Serological testing revealed antinuclear antibody (ANA) positivity and Borrelia burgdorferi IgG seropositivity in serum without evidence of intrathecal antibody synthesis. After exclusion of infectious, ischemic, and vasculitic etiologies, the diagnosis of probable CAA-RI was established according to the Boston criteria version 2.0, based on the clinical presentation and characteristic MRI findings, including white matter hyperintensities in a multispot pattern. High-dose intravenous corticosteroid therapy was initiated, resulting in marked clinical improvement. The diagnosis of CAA-RI was supported by the overall patient presentation, characteristic imaging findings, exclusion of alternative etiologies, and response to immunosuppressive treatment. This case highlights the diagnostic challenge of distinguishing CAA-RI from PRES and emphasizes the importance of early recognition to enable timely treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.